Filters
| Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
|---|---|---|---|
Knight Diagnostic Laboratories - Molecular Diagnostic Center Oregon Health & Science University United States | 33 | 49 |
|
Invitae Common Hereditary Cancers Panel (Breast, Gyn, GI) Invitae United States | 75 | 42 |
|
Hereditary Cancer Panel, Sequencing and Deletion/Duplication ARUP Laboratories, Molecular Genetics and Genomics ARUP Laboratories United States | 33 | 73 |
|
Breast and Ovarian Cancer - extended Diagnostic Panel CeGaT GmbH Germany | 7 | 41 |
|
Hereditary Breast and Gynecological Cancers Panel, Sequencing and Deletion/Duplication ARUP Laboratories, Molecular Genetics and Genomics ARUP Laboratories United States | 15 | 23 |
|
King Laboratory University Of Washington United States | 4 | 7 |
|
Invitae United States | 19 | 14 |
|
Asper Biogene Asper Biogene LLC Estonia | 135 | 98 |
|
Fulgent Genetics United States | 1 | 1 |
|
Invitae Breast and Gyn Cancers Panel Invitae United States | 33 | 23 |
|
Fulgent Genetics United States | 5129 | 4672 |
|
Hereditary Breast and Ovarian Cancer Institute of Human Genetics Universitätsmedizin Greifswald Germany | 6 | 11 |
|
Asper Biogene Asper Biogene LLC Estonia | 15 | 23 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.